Prokarium

United Kingdom
Newdigate, England, United Kingdom, NW1 0NH

Company profile

Prokarium company profile

Prokarium is a biopharmaceutical company leading the oncology field of microbial immunotherapy The Company’s pipeline is designed to unlock a new generation of immuno-oncology therapeutics by re engineering evolution into a synthetic biology platform Prokarium’s lead program is focused on transforming the treatment paradigm in bladder cancer by orchestrating immune driven, long lasting antitumor effects

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2012-01-01, Year

Headquarters

Postal code
NW1 0NH
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
8
Total equity funding
$69M
Last funding
Series B / $30M / 2023-02-09
Last equity funding
Series B / $30M
Investors
8
Lead investors
4
Founders
1
Articles
31

Founders and investors

Founders

Rocky Cranenburgh

Lead investors

Flerie InvestKorea Investment PartnersRiyadh Valley CompanyWellcome Trust

Investors

Innovate UKKorea Investment PartnersSynbiCITEThe Future FundWellcome Trust